Innovation Pharmaceuticals Inc (IPIX)

[Empiricst1]

"They are years away from coming to market if at all but world has moved on and got better alternatives." You make and repeat some good points, but not this one. Brilacidin for ABSSSI? The market has moved on from MRSA anti-biotics? hardly; Prurisol, not seen the Ph2b data so hard to say; Kevetrin, not even PH2a has been completed, etc.; Brilacidin for IBD/Crohn's/UC, vast market awaits an expanding variety of treatments; Brilacidin for OM is actually one use that will become less relevant as chemo/radiation slowly gives way to immunologic and similar novel therapies, in a decade or two.